Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Nephrotic syndrome and its complications

Renal · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

New nephrotic syndrome with breathlessness, pleuritic pain, unilateral swelling, sepsis, oliguria, severe intravascular depletion, pulmonary oedema or rapidly worsening kidney function requires same-day hospital assessment. Suspect venous thromboembolism even when oedema seems to explain the limb findings, and involve nephrology early rather than starting empirical immunosuppression.

Synopsis

Recognise the nephrotic phenotype, identify a treatable glomerular cause, and prevent thrombosis, infection, acute kidney injury and harmful over-diuresis while specialist assessment proceeds.

  • Adult nephrotic syndrome combines heavy glomerular protein loss, hypoalbuminaemia and oedema; hyperlipidaemia and lipiduria are supportive consequences rather than essential diagnostic criteria.
  • Quantify urine protein with a laboratory protein:creatinine ratio because albumin-only measurement can underestimate non-albumin proteins and a dipstick is concentration-dependent.
  • Primary causes include minimal change disease, focal segmental glomerulosclerosis and membranous nephropathy; diabetes, lupus, amyloid, infection, medicines and malignancy are important secondary causes.
  • Generalised oedema does not prove intravascular excess: low oncotic pressure, diuretics, diarrhoea and sepsis can leave a visibly oedematous patient hypotensive and kidney under-perfused.
  • Urinary antithrombin loss, increased hepatic procoagulant synthesis and immobility produce substantial venous thromboembolism risk, especially with profound hypoalbuminaemia and membranous nephropathy.
  • Fever, abdominal pain or subtle deterioration may represent serious infection because immunoglobulin and complement losses, oedematous tissue and immunosuppression impair defence.
  • Acute kidney injury may reflect hypovolaemia, sepsis, interstitial oedema, renal-vein thrombosis, drug toxicity or the underlying glomerular lesion; do not label every creatinine rise as disease progression.
  • Salt restriction and carefully titrated loop diuresis treat symptomatic oedema, but daily weights, blood pressure, creatinine and electrolytes must guide the pace of fluid removal.
  • ACE inhibition or ARB therapy can reduce proteinuria after haemodynamic stability is established; never combine the two, and review potassium and kidney function after initiation or titration.
  • Prophylactic anticoagulation is not automatic: nephrology weighs albumin, histology, bleeding risk, mobility, previous thrombosis and anticipated biopsy or procedures.
  • Kidney biopsy usually defines non-diabetic adult disease, but the indication and timing depend on phenotype, diabetes history, serology, bleeding risk and whether histology will alter treatment.

Key red flags

Possible pulmonary embolism

Sudden dyspnoea, pleuritic pain, syncope, tachycardia, hypoxaemia or asymmetric leg swelling is not explained away by nephrotic oedema and requires an urgent VTE pathway.

Renal-vein thrombosis

Flank pain, macroscopic haematuria, abrupt kidney dysfunction or unexplained worsening proteinuria can signal renal-vein thrombosis, but presentation may be silent and imaging choice depends on kidney function.

Serious infection

Fever, abdominal tenderness, cellulitis, cough, confusion or an unexplained fall in blood pressure may indicate bacterial infection and warrants cultures and prompt sepsis assessment.

Investigation priorities

01
Urine PCR, ACR and urinalysisFirst step

Confirm and characterise glomerular protein loss while looking for haematuria or infection.

Management branches

First presentationConfirm, stabilise and find the cause

Heavy proteinuria with hypoalbuminaemia, oedema or an otherwise convincing nephrotic presentation.

  1. Assess ABCDE, perfusion and true fluid state; look actively for sepsis, VTE, pulmonary oedema, oliguria and other reasons for immediate admission.
  2. Quantify total urine protein, establish kidney-function and albumin trends, review systemic disease, infection, malignancy and medicine exposures, and send focused secondary-cause tests.
  3. Discuss early with nephrology for biopsy planning, complication-risk assessment and disease-specific treatment; avoid empirical glucocorticoids in an undiagnosed adult unless a specialist directs them.

Key medicines

Loop diureticDose and route are individualised to congestion, kidney function and prior exposure; follow the local renal prescription.Excess treatment causes hypotension, electrolyte loss, ototoxicity at high intravenous exposure and prerenal AKI; daily reassessment is essential.
ACE inhibitor or ARBStart one agent at a low licensed dose after stabilisation, then titrate with specialist-agreed biochemical checks.Do not combine classes; pause or review during hypovolaemia, severe AKI or hyperkalaemia, and address pregnancy potential before prescribing.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • KDIGO glomerular diseases guideline suiteInternational primary guidance on nephrotic complications, supportive care and disease-specific glomerular treatment.
  • NICE NG203 chronic kidney disease recommendationsUK framework for proteinuria measurement, renin–angiotensin blockade, monitoring and specialist referral.
  • NICE NG158 venous thromboembolic diseasesUK diagnostic and treatment pathway for suspected and confirmed VTE.
  • UK Kidney Association guideline catalogueUK renal guidance and implementation resources, including glomerular and anticoagulation material.
  • BNF furosemide monographLicensed UK dosing, renal considerations, interactions and adverse-effect safeguards for loop diuresis.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom